Lv7
3969 积分 2021-01-15 加入
Preclinical Characterization of Novel FAP-2286-Based Radioligand with Albumin Binder for Improved Tumor Retention
2天前
已关闭
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
4天前
已完结
Overcoming cancer therapy resistance: From drug innovation to therapeutics
9天前
已完结
Homogeneous multi-payload antibody–drug conjugates
9天前
已完结
Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach
11天前
已关闭
Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer
16天前
已完结
Exploiting Synthetic Lethality in PDAC with Antibody Drug Conjugates and ATR inhibition
16天前
已完结
2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
18天前
已关闭
PSMA-targeted Small Molecule-Drug Conjugates based on a Post-Prolyl Peptidase Cleavable Linker for the Treatment of Prostate Cancer
21天前
已完结
Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age
21天前
已完结
皖公网安备34019202002308
